TY - JOUR
T1 - Unreliability of Depopulated Bovine Ureteric Xenograft for Infra Inguinal Bypass Surgery
T2 - Mid-term Results from Two Vascular Centres
AU - Tolva, V.
AU - Bertoni, G. B.
AU - Trimarchi, S.
AU - Grassi, V.
AU - Fusari, M.
AU - Rampoldi, V.
PY - 2007/2
Y1 - 2007/2
N2 - Introduction: We report a two centre experience with a depopulated ureteric xenograft (SGVG 100
®, CryoLife Inc., GA, USA) for femoropopliteal revascularization in 12 patients with chronic critical limb ischemia. Report: Between 7 days and 18 months after implantation, 10 of 12 patients (1 lost to follow-up) had the graft explanted due to aneurysmal enlargement. At 5 years, only one graft was still patent and showed moderate signs of enlargement. Conclusion: The SGVG 100
® is not a safe conduit for femoropopliteal bypass surgery.
AB - Introduction: We report a two centre experience with a depopulated ureteric xenograft (SGVG 100
®, CryoLife Inc., GA, USA) for femoropopliteal revascularization in 12 patients with chronic critical limb ischemia. Report: Between 7 days and 18 months after implantation, 10 of 12 patients (1 lost to follow-up) had the graft explanted due to aneurysmal enlargement. At 5 years, only one graft was still patent and showed moderate signs of enlargement. Conclusion: The SGVG 100
® is not a safe conduit for femoropopliteal bypass surgery.
KW - Bypass surgery
KW - Critical limb ischemia
KW - Graft
KW - Infection
KW - Xenograft
UR - http://www.scopus.com/inward/record.url?scp=33846153548&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846153548&partnerID=8YFLogxK
U2 - 10.1016/j.ejvs.2006.10.007
DO - 10.1016/j.ejvs.2006.10.007
M3 - Article
C2 - 17127082
AN - SCOPUS:33846153548
VL - 33
SP - 214
EP - 216
JO - European Journal of Vascular and Endovascular Surgery
JF - European Journal of Vascular and Endovascular Surgery
SN - 1078-5884
IS - 2
ER -